Showing 1 - 10 of 727
Hepatitis B and C are viruses that infect the liver and can silently progress to become serious diseases such as cirrhosis and liver cancer. Effective antiviral treatment is available and timely treatment of eligible patients can prevent hepatitis-related burden of disease and death. The main...
Persistent link: https://www.econbiz.de/10015292664
Persistent link: https://www.econbiz.de/10003688599
Persistent link: https://www.econbiz.de/10004954864
Persistent link: https://www.econbiz.de/10009623990
Persistent link: https://www.econbiz.de/10009623991
Persistent link: https://www.econbiz.de/10014381292
Persistent link: https://www.econbiz.de/10015285324
The global burden of disease due to hepatitis B and C virus infection is high, and chronic infection with these viruses can lead to cirrhosis, liver failure and hepatocellular carcinoma. Effective treatments exist for both chronic hepatitis B and C; however, the treatment regimen to be given for...
Persistent link: https://www.econbiz.de/10015285335
A Council Recommendation dated 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) outlines the threat that AMR poses to human health and advocates a range of actions to be taken for its prevention and control. Council Conclusions on antimicrobial...
Persistent link: https://www.econbiz.de/10015285351